Authors:
Kanda, Y
Arai, C
Chizuka, A
Yamamoto, R
Hamaki, T
Suguro, M
Matsuyama, T
Takezako, N
Miwa, A
Tohma, J
Shirakawa, K
Yatomi, T
Nakamura, N
Hirai, H
Togawa, A
Citation: Y. Kanda et al., Lack of correlation between clinical characteristics and serum soluble Fasligand levels in patients with multiple myeloma, LEUK LYMPH, 40(3-4), 2001, pp. 351-356
Authors:
Suzuki, K
Endo, R
Nakamura, N
Yatomi, T
Iwai, M
Abe, K
Takikawa, Y
Sato, S
Citation: K. Suzuki et al., Serum levels of soluble Fas ligand in patients with acute and fulminant hepatitis: relationship with soluble Fas, tumor necrosis factor alpha and TNFreceptor-1, HEPATOL RES, 17(1), 2000, pp. 19-30
Authors:
Kanda, Y
Chiba, S
Tanaka, Y
Kami, M
Saito, T
Izutsu, K
Asai, T
Yuji, K
Ogawa, S
Honda, H
Mitani, K
Usuki, K
Urabe, A
Shirakawa, K
Yatomi, T
Nakamura, N
Yazaki, Y
Hirai, H
Citation: Y. Kanda et al., Increased serum soluble Fas ligand associated with recurrent B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation, LEUK LYMPH, 34(5-6), 1999, pp. 625-628
Authors:
Kuwano, K
Hagimoto, N
Kawasaki, M
Yatomi, T
Nakamura, N
Nagata, S
Suda, T
Kunitake, R
Maeyama, T
Miyazaki, H
Hara, N
Citation: K. Kuwano et al., Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis, J CLIN INV, 104(1), 1999, pp. 13-19